Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter and Year ended March 31, 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 28 2025
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 21 2025
- Board Meeting Outcome for Allotment Of Equity Share Warrants.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Feb 14 2025
Later from Venmax Drugs & Pharmaceuticals
- Resignation Of Ms. Pratibha Jhawar From The Post Of Company Secretary & Compliance Officer
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 21 2025
- Change In Key Management
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 26 2025
- Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended March 31St, 2025.
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals